Market Tracker

11/27 4:45pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

89.38
Data as of Nov 26
 -0.07 / -0.08%
Today’s Change
55.04
Today|||52-Week Range
91.40
+27.05%
Year-to-Date

Today’s Trading

Previous close89.45
Today’s open89.55
Day’s range88.01 - 89.95
Volume920,243
Average volume (3 months)1,146,426
Market cap$13.2B
Dividend yield--
Data as of 3:59pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)-34.74%
Earnings growth (this year)+18.66%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+10.82%
P/E ratioNM
Price/Sales17.67
Price/Book9.56

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+1.87+2.56%
ENDPEndo International P...+0.19+0.26%
PCYCPharmacyclics Inc+0.68+0.49%
MNKMallinckrodt Plc+0.73+0.80%
Data as of 4:05pm ET, 11/26/2014

Financials

Next reporting dateFebruary 19, 2015
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$548.4M
Annual profit (last year)-$176.4M
Net profit margin-32.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts